Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [4]
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN395159 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Hemochromatosis (HFE) (AA 115-206) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 115-206
- Isotype
- IgG
- Antibody clone number
- 1G12
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project.
Hemochromatosis genotypes and risk of iron overload--a meta-analysis.
Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease.
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis.
Serum iron parameters, HFE C282Y genotype, and cognitive performance in older adults: results from the FACIT study.
Lehmann DJ, Schuur M, Warden DR, Hammond N, Belbin O, Kölsch H, Lehmann MG, Wilcock GK, Brown K, Kehoe PG, Morris CM, Barker R, Coto E, Alvarez V, Deloukas P, Mateo I, Gwilliam R, Combarros O, Arias-Vásquez A, Aulchenko YS, Ikram MA, Breteler MM, van Duijn CM, Oulhaj A, Heun R, Cortina-Borja M, Morgan K, Robson K, Smith AD
Neurobiology of aging 2012 Jan;33(1):202.e1-13
Neurobiology of aging 2012 Jan;33(1):202.e1-13
Hemochromatosis genotypes and risk of iron overload--a meta-analysis.
Neghina AM, Anghel A
Annals of epidemiology 2011 Jan;21(1):1-14
Annals of epidemiology 2011 Jan;21(1):1-14
Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease.
Valenti L, Canavesi E, Galmozzi E, Dongiovanni P, Rametta R, Maggioni P, Maggioni M, Fracanzani AL, Fargion S
Journal of hepatology 2010 Nov;53(5):927-33
Journal of hepatology 2010 Nov;53(5):927-33
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis.
Phatak P, Brissot P, Wurster M, Adams PC, Bonkovsky HL, Gross J, Malfertheiner P, McLaren GD, Niederau C, Piperno A, Powell LW, Russo MW, Stoelzel U, Stremmel W, Griffel L, Lynch N, Zhang Y, Pietrangelo A
Hepatology (Baltimore, Md.) 2010 Nov;52(5):1671-779
Hepatology (Baltimore, Md.) 2010 Nov;52(5):1671-779
Serum iron parameters, HFE C282Y genotype, and cognitive performance in older adults: results from the FACIT study.
Schiepers OJ, van Boxtel MP, de Groot RH, Jolles J, de Kort WL, Swinkels DW, Kok FJ, Verhoef P, Durga J
The journals of gerontology. Series A, Biological sciences and medical sciences 2010 Dec;65(12):1312-21
The journals of gerontology. Series A, Biological sciences and medical sciences 2010 Dec;65(12):1312-21
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA